Other AD-related proteins such as pTau-S396, pTau-S404, and APOE were also downregulated by NGFR (Fig. 5b, Supplementary Data 8), suggesting that activation of Ngfr signaling in DG and particularly in astroglia could improve AD pathology burden. This evidence concerns the gene APOE and Alzheimer disease.